173 related articles for article (PubMed ID: 9305709)
1. Telomerase activity in ovarian tumors.
Murakami J; Nagai N; Ohama K; Tahara H; Ide T
Cancer; 1997 Sep; 80(6):1085-92. PubMed ID: 9305709
[TBL] [Abstract][Full Text] [Related]
2. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
3. [Telomerase activity and telomere length as diagnostic tumor marker for ovarian tumors].
Murakami J; Nagai N; Ohama K
Nihon Rinsho; 1998 May; 56(5):1310-5. PubMed ID: 9613143
[TBL] [Abstract][Full Text] [Related]
4. The relationship between telomere length and telomerase activity in gynecologic cancers.
Wang SJ; Sakamoto T; Yasuda Si S; Fukasawa I; Ota Y; Hayashi M; Okura T; Zheng JH; Inaba N
Gynecol Oncol; 2002 Jan; 84(1):81-4. PubMed ID: 11748981
[TBL] [Abstract][Full Text] [Related]
5. Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas.
Datar RH; Naritoku WY; Li P; Tsao-Wei D; Groshen S; Taylor CR; Imam SA
Gynecol Oncol; 1999 Sep; 74(3):338-45. PubMed ID: 10479490
[TBL] [Abstract][Full Text] [Related]
6. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
[TBL] [Abstract][Full Text] [Related]
7. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
Wu K; Lund M; Bang K; Thestrup-Pedersen K
Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity in neuroendocrine tumors.
Bockhorn M; Frilling A; Clauer U; Hertl M; Broelsch CE
Int J Surg Investig; 2000; 2(3):219-25. PubMed ID: 12678522
[TBL] [Abstract][Full Text] [Related]
9. Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
Patel MM; Parekh LJ; Jha FP; Sainger RN; Patel JB; Patel DD; Shah PM; Patel PS
Head Neck; 2002 Dec; 24(12):1060-7. PubMed ID: 12454944
[TBL] [Abstract][Full Text] [Related]
10. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity and alterations in telomere length in human brain tumors.
Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N
Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755
[TBL] [Abstract][Full Text] [Related]
12. The telomerase activity and expression of hTERT gene can serve as indicators in the anti-cancer treatment of human ovarian cancer.
Sun PM; Wei LH; Luo MY; Liu G; Wang JL; Mustea A; Könsgen D; Lichtenegger W; Sehouli J
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):249-57. PubMed ID: 16519988
[TBL] [Abstract][Full Text] [Related]
13. Analysis of telomerase activity and telomere function in cancer.
Gordon KE; Parkinson EK
Methods Mol Biol; 2004; 281():333-48. PubMed ID: 15220541
[TBL] [Abstract][Full Text] [Related]
14. Telomeric instability and reduced proliferative potential in ovarian surface epithelial cells from women with a family history of ovarian cancer.
Kruk PA; Godwin AK; Hamilton TC; Auersperg N
Gynecol Oncol; 1999 May; 73(2):229-36. PubMed ID: 10329039
[TBL] [Abstract][Full Text] [Related]
15. Consistent decrease in telomere length in parathyroid tumors but alteration in telomerase activity limited to malignancies: preliminary report.
Kammori M; Nakamura K; Kanauchi H; Obara T; Kawahara M; Mimura Y; Kaminishi M; Takubo K
World J Surg; 2002 Sep; 26(9):1083-7. PubMed ID: 12209236
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity in giant cell tumors of bone.
Matsuo T; Hiyama E; Sugita T; Shimose S; Kubo T; Mochizuki Y; Adachi N; Kojima K; Sharman P; Ochi M
Ann Surg Oncol; 2007 Oct; 14(10):2896-902. PubMed ID: 17653593
[TBL] [Abstract][Full Text] [Related]
17. Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
Yeh TS; Cheng AJ; Chen TC; Jan YY; Hwang TL; Jeng LB; Chen MF; Wang TC
J Surg Res; 1999 Dec; 87(2):171-7. PubMed ID: 10600346
[TBL] [Abstract][Full Text] [Related]
18. Quantitative differences in telomerase activity among malignant, premalignant, and benign ovarian lesions.
Kyo S; Takakura M; Tanaka M; Murakami K; Saitoh R; Hirano H; Inoue M
Clin Cancer Res; 1998 Feb; 4(2):399-405. PubMed ID: 9516928
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity in human renal cell carcinoma.
Mehle C; Piatyszek MA; Ljungberg B; Shay JW; Roos G
Oncogene; 1996 Jul; 13(1):161-6. PubMed ID: 8700542
[TBL] [Abstract][Full Text] [Related]
20. [Telomere lengths and telomerase activity in liposarcomas].
Schneider-Stock R; Eppler C; Walter H; Radig K; Haeckel C; Hoang-Vu C; Epplen JT; Roessner A
Verh Dtsch Ges Pathol; 1998; 82():226-31. PubMed ID: 10095439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]